04/17/2024
4:19 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024
3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024
3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024
3:44 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
5:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/21/2024
3:20 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:25 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:33 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:15 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:19 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:32 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:33 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:47 PM | Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:22 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:22 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:55 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:11 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:51 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:40 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:43 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:45 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:48 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:27 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:17 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
3:18 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2024
6:46 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
02/08/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:25 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:28 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:12 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:15 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:24 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:26 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:29 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:00 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:05 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:11 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:14 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:43 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
4:04 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:47 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
10:52 AM | BlackRock Inc. (Filed by)
Neurocrine Biosciences (Subject)
| Form SC 13G/A | |
01/22/2024
3:17 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:31 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:15 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:26 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:32 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:31 PM | Neurocrine Biosciences (Subject)
RASTETTER WILLIAM H (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:31 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:08 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:10 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:15 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:21 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
3:22 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
3:22 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
4:22 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:18 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
6:09 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
5:23 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:32 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:33 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:54 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
7:01 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
4:41 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
3:36 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
3:12 PM | Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
6:02 AM | Neurocrine Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
The Gold Grab of the Century (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
10/06/2023
8:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:51 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:09 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
6:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
3:36 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:31 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:16 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
